THYROCARE · Thyrocare Technologies Limited · Financials
Volume · Nov 13
12.8K
Avg daily vol (3M)
56.88K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
8.29B
+20.6%
FY2026
Net Income
1.63B
+78.2%
FY2026
Operating Cash Flow
2.13B
+11.5%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|---|
| INR | 9.3B | 8.29B | 6.87B | 5.72B | 5.27B | 5.89B | 4.95B | 4.33B | 4.03B |
| INR | 616.7M | 585.8M | 552.6M | 470.1M | 387.1M | 338.7M | 302.8M | 319.1M | 261.7M |
| INR | 43.5M | 28M | 30.5M | 42M | 23.5M | 23.7M | 8.7M | 18.5M | 6.1M |
| INR | 584.6M | 500.3M | 546.9M | 264.9M | 242.3M | 515.8M | 393.2M | 520.1M | 529.2M |
| INR | 1.44B | 1.63B | 915.1M | 707.6M | 644.9M | 1.76B | 0 | 884.1M | 0 |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 4.98B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.